Methocarbamol
- Product NDC
- 61919-616
- Requested package NDC
- 61919-616-90
- 11-digit product format
- 619190616
- Labeler code
- 61919
- Product ID
- 61919-616_47e1580c-5da2-4f45-e063-6294a90ab181
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methocarbamol
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA209312
- Marketing category
- ANDA
- Marketing start
- 2019-04-18
- Substance
- METHOCARBAMOL
- Active strength
- 750 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 61919-616 | 61919-616-90 | I | Inactivated by FDA | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | 1332a3947898… | d4bfe170f9cd… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209312-001 | METHOCARBAMOL | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 |
| A209312-002 | METHOCARBAMOL | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209312-001 | AA |
| A209312-002 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2018-05-07 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A209312-001 | AA | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209312-002 | AA | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209312-001 | AA | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209312-002 | AA | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209312-001 | AA | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209312-002 | AA | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209312-001 | AA | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209312-002 | AA | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209312-001 | AA | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209312-002 | AA | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209312-001 | AA | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209312-002 | AA | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209312-001 | AA | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209312-002 | AA | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209312-001 | AA | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209312-002 | AA | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209312-001 | AA | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209312-002 | AA | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A209312-001 | AA | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A209312-002 | AA | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209312-001 | AA | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209312-002 | AA | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209312-001 | AA | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209312-002 | AA | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209312-001 | AA | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209312-002 | AA | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A209312-001 | AA | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A209312-002 | AA | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209312-001 | AA | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209312-002 | AA | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A209312-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A209312-002 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A209312-001 | AA | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A209312-002 | AA | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A209312-001 | AA | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A209312-002 | AA | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A209312-001 | AA | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A209312-002 | AA | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A209312-001 | AA | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A209312-002 | AA | 1 | 782e0a99824c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Methocarbamol
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| METHOCARBAMOL | 750 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 125OD7737X | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 31508051-c9cb-149b-e054-00144ff88e88 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 492965be-47bc-38cf-57c4-5c5e0343abe5 | Product name | 6 | 20211028 |
| 02a01e9c-3f4e-c0ee-6542-be865127aea3 | Product name | 8 | 20190205 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61919-616-40 | 2023-01-30 | C162847 | 48780-1 | f386c64a-115f-0266-e053-dadaa90a7c1a | METHOCARBAMOL 750mg |
| 61919-616-72 | 2023-01-30 | C162847 | 48780-1 | f386c649-da2a-0266-e053-dadaa90a7c1a | METHOCARBAMOL 750mg |
| 61919-616-90 | 2023-01-30 | C162847 | 48780-1 | f386c649-a12f-0266-e053-dadaa90a7c1a | METHOCARBAMOL 750mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61919-616-20 | Methocarbamol | 20 in 1 BOTTLE | TABLET, COATED | 20 | 16 | |
| 61919-616-30 | Methocarbamol | 30 in 1 BOTTLE | TABLET, COATED | 30 | 16 | |
| 61919-616-60 | Methocarbamol | 60 in 1 BOTTLE | TABLET, COATED | 60 | 16 | |
| 61919-616-40 | Methocarbamol | 40 in 1 BOTTLE | TABLET, COATED | 40 | 1 | |
| 61919-616-72 | Methocarbamol | 120 in 1 BOTTLE | TABLET, COATED | 120 | 1 | |
| 61919-616-90 | Methocarbamol | 90 in 1 BOTTLE | TABLET, COATED | 90 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 61919-616-20 | EA - Each | 61919-616 | 985fd0a6-95e0-41c4-ada0-706cfde63b15 | 1 | 2024-10-04 |
| 61919-616-30 | EA - Each | 61919-616 | f20e623c-3f38-4fd8-8c4e-d17eacfe4fea | 1 | 2019-05-02 |
| 61919-616-40 | EA - Each | 61919-616 | bd01fdca-e495-450f-8922-5078f5c3af78 | 1 | 2019-09-05 |
| 61919-616-60 | EA - Each | 61919-616 | 83d7aa01-4fb4-47a7-a55a-44c25f70317d | 1 | 2022-11-07 |
| 61919-616-72 | EA - Each | 61919-616 | 2a41835b-6af3-41ac-9146-61eb10aaff32 | 1 | 2019-09-05 |
| 61919-616-90 | EA - Each | 61919-616 | 72a9a91b-bc6e-47d7-a241-057556495fd2 | 1 | 2019-09-05 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61919-616 | METHOCARBAMOL TABLET, COATED METHOCARBAMOL TABLET [DIRECT RX] | 15 | Current NDC, Legacy NDC, 3 package rows | 20240915_31508051-c9cb-149b-e054-00144ff88e88.zip |
| 61919-616 | METHOCARBAMOL TABLET, COATED [DIRECT_RX] | 1 | Current NDC, Legacy NDC, 1 package rows | 20190823_90b9b911-a1f3-cfe2-e053-2a95a90a927e.zip |
| 61919-616 | METHOCARBAMOL TABLET, COATED [DIRECT_RX] | 1 | Current NDC, Legacy NDC, 1 package rows | 20190828_911ec9f9-7d5b-5452-e053-2a95a90aea45.zip |
| 61919-616 | METHOCARBAMOL TABLET, COATED [DIRECT_RX] | 1 | Current NDC, Legacy NDC, 1 package rows | 20190823_90b98f8e-8805-520c-e053-2a95a90a31b8.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 52b20439-6bf4-435e-817a-c3b3fc70846a | 2026-07-10 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 37767123-8b72-4e1f-b00d-ff3305e9923f | 2026-07-10 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Unit Dose Solutions, Inc. | 561ae476-9e1f-038a-e063-6394a90aa5c7 | 2026-07-08 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Granules Pharmaceuticals Inc. | 6f0d3966-962d-fa7c-e053-2a91aa0a8e3c | 2026-07-07 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Bryant Ranch Prepack | 65c460f6-6470-41ff-abb4-d9d54ecc52f7 | 2026-07-06 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | St. Mary's Medical Park Pharmacy | 7d4dd78a-f902-6ff2-e053-2991aa0ac7d7 | 2026-06-26 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Preferred Pharmaceuticals Inc. | 43f83b87-e169-46fe-98bd-6af373595bd3 | 2026-06-23 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Preferred Pharmaceuticals Inc. | e03878d3-d780-4e7f-b828-20ac2a109933 | 2026-06-23 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Coupler LLC | 52b87514-e6e0-ab57-e063-6394a90a6b23 | 2026-05-26 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 71c21226-cd96-33ed-e053-2995a90a5269 | 2026-05-22 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | St. Mary's Medical Park Pharmacy | faa81ad3-2bd2-d637-e053-6294a90a2d36 | 2026-05-10 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Proficient Rx LP | 23163bc1-dec7-41f6-baed-eedebfd6be7e | 2026-05-01 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 1dc3a5b1-c83b-406b-a59d-ce8075e4ccf9 | 2026-04-28 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Advanced Rx of Tennessee, LLC | 4de118fe-bd8e-6cc4-e063-6394a90a1320 | 2026-03-25 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Advanced Rx of Tennessee, LLC | 4cefe51c-d824-a862-e063-6394a90a7717 | 2026-03-13 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Redpharm Drug | 44f264fd-bf40-bed9-e063-6294a90ac44a | 2026-03-05 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 72f36d28-15d2-30f6-e053-2a91aa0ad1ce | 2026-01-30 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Northwind Health Company, LLC | f2b4ed95-0469-393a-e053-2a95a90a98ed | 2026-01-19 | Warnings, Adverse reactions | 209312 ANDA209312 |
| METHOCARBAMOL | METHOCARBAMOL | DIRECT RX | 31508051-c9cb-149b-e054-00144ff88e88 | 2026-01-08 | Warnings, Adverse reactions | 209312 ANDA209312 61919-616 |
| Methocarbamol | METHOCARBAMOL TABLETS | Northwind Health Company, LLC | f2b4ed5f-3489-9ee4-e053-2995a90a25f0 | 2026-01-01 | Warnings, Adverse reactions | 209312 ANDA209312 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197943 | methocarbamol 500 MG Oral Tablet | PSN | 31508051-c9cb-149b-e054-00144ff88e88 | 16 |
| 197944 | methocarbamol 750 MG Oral Tablet | PSN | 31508051-c9cb-149b-e054-00144ff88e88 | 16 |
| 197943 | methocarbamol 500 MG Oral Tablet | SCD | 31508051-c9cb-149b-e054-00144ff88e88 | 16 |
| 197944 | methocarbamol 750 MG Oral Tablet | SCD | 31508051-c9cb-149b-e054-00144ff88e88 | 16 |
| 197944 | methocarbamol 750 MG Oral Tablet | PSN | 90b98f8e-8805-520c-e053-2a95a90a31b8 | 1 |
| 197944 | methocarbamol 750 MG Oral Tablet | PSN | 90b9b911-a1f3-cfe2-e053-2a95a90a927e | 1 |
| 197944 | methocarbamol 750 MG Oral Tablet | PSN | 911ec9f9-7d5b-5452-e053-2a95a90aea45 | 1 |
| 197944 | methocarbamol 750 MG Oral Tablet | SCD | 90b98f8e-8805-520c-e053-2a95a90a31b8 | 1 |
| 197944 | methocarbamol 750 MG Oral Tablet | SCD | 90b9b911-a1f3-cfe2-e053-2a95a90a927e | 1 |
| 197944 | methocarbamol 750 MG Oral Tablet | SCD | 911ec9f9-7d5b-5452-e053-2a95a90aea45 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 61919-616-90 | 61919061690 | 90 TABLET, COATED in 1 BOTTLE (61919-616-90) | 2019-08-27 | 0000-00-00 | No | No | Current |